JP2022526507A5 - - Google Patents

Info

Publication number
JP2022526507A5
JP2022526507A5 JP2021556866A JP2021556866A JP2022526507A5 JP 2022526507 A5 JP2022526507 A5 JP 2022526507A5 JP 2021556866 A JP2021556866 A JP 2021556866A JP 2021556866 A JP2021556866 A JP 2021556866A JP 2022526507 A5 JP2022526507 A5 JP 2022526507A5
Authority
JP
Japan
Application number
JP2021556866A
Other languages
Japanese (ja)
Other versions
JPWO2020201078A5 (https=
JP7575400B2 (ja
JP2022526507A (ja
Filing date
Publication date
Priority claimed from EP19166382.2A external-priority patent/EP3715851A1/en
Application filed filed Critical
Priority claimed from PCT/EP2020/058700 external-priority patent/WO2020201078A1/en
Publication of JP2022526507A publication Critical patent/JP2022526507A/ja
Publication of JPWO2020201078A5 publication Critical patent/JPWO2020201078A5/ja
Publication of JP2022526507A5 publication Critical patent/JP2022526507A5/ja
Priority to JP2024181851A priority Critical patent/JP2025015545A/ja
Application granted granted Critical
Publication of JP7575400B2 publication Critical patent/JP7575400B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021556866A 2019-03-29 2020-03-27 バイオマーカーに基づく遠隔患者管理の処方 Active JP7575400B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024181851A JP2025015545A (ja) 2019-03-29 2024-10-17 バイオマーカーに基づく遠隔患者管理の処方

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
EP19166425.9 2019-03-29
EP19166382.2A EP3715851A1 (en) 2019-03-29 2019-03-29 Prescription of remote patient management based on biomarkers
EP19166382.2 2019-03-29
EP19166425 2019-03-29
EP19175720.2 2019-05-21
EP19175720 2019-05-21
PCT/EP2020/058700 WO2020201078A1 (en) 2019-03-29 2020-03-27 Prescription of remote patient management based on biomarkers

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024181851A Division JP2025015545A (ja) 2019-03-29 2024-10-17 バイオマーカーに基づく遠隔患者管理の処方

Publications (4)

Publication Number Publication Date
JP2022526507A JP2022526507A (ja) 2022-05-25
JPWO2020201078A5 JPWO2020201078A5 (https=) 2023-04-05
JP2022526507A5 true JP2022526507A5 (https=) 2023-04-05
JP7575400B2 JP7575400B2 (ja) 2024-10-29

Family

ID=69941398

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021556866A Active JP7575400B2 (ja) 2019-03-29 2020-03-27 バイオマーカーに基づく遠隔患者管理の処方
JP2024181851A Pending JP2025015545A (ja) 2019-03-29 2024-10-17 バイオマーカーに基づく遠隔患者管理の処方

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024181851A Pending JP2025015545A (ja) 2019-03-29 2024-10-17 バイオマーカーに基づく遠隔患者管理の処方

Country Status (8)

Country Link
US (2) US12442825B2 (https=)
EP (1) EP3948301A1 (https=)
JP (2) JP7575400B2 (https=)
CN (1) CN113348368A (https=)
AU (1) AU2020253042B2 (https=)
BR (1) BR112021019479A2 (https=)
CA (3) CA3281050A1 (https=)
WO (1) WO2020201078A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11783944B2 (en) * 2019-09-09 2023-10-10 Neal F. Krouse System for live monitoring of vitals for patients and physicians
WO2022101937A1 (en) * 2020-11-12 2022-05-19 Shah Komal An integrated health data capture and analysis based device for evaluation, diagnosis and prognosis of heart failure
WO2022164724A1 (en) * 2021-01-27 2022-08-04 Verantos, Inc. High validity real-world evidence study with deep phenotyping
WO2022245405A1 (en) 2021-05-17 2022-11-24 Verantos, Inc. System and method for term disambiguation
US20240120105A1 (en) * 2022-10-09 2024-04-11 Morteza Naghavi Predicting adverse health risk based on ct scan images and ai-enabled cardiovascular structure volumetry
WO2025097159A1 (en) * 2023-11-05 2025-05-08 3Ive Labs, Llc Urinary oxygen and uses thereof in adaptive therapies for kidney function

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3943918A (en) 1971-12-02 1976-03-16 Tel-Pac, Inc. Disposable physiological telemetric device
US4121573A (en) 1973-10-04 1978-10-24 Goebel Fixture Co. Wireless cardiac monitoring system and electrode-transmitter therefor
FR2570703B1 (fr) 1984-09-26 1988-07-08 Commissariat Energie Atomique Complexes macropolycycliques de terres rares et application a titre de marqueurs fluorescents
US4827943A (en) 1986-09-23 1989-05-09 Advanced Medical Technologies, Inc. Portable, multi-channel, physiological data monitoring system
US4784162A (en) 1986-09-23 1988-11-15 Advanced Medical Technologies Portable, multi-channel, physiological data monitoring system
US4882733A (en) 1987-03-13 1989-11-21 Ford Aerospace Corporation Method and apparatus for combining encoding and modulation
US5511553A (en) 1989-02-15 1996-04-30 Segalowitz; Jacob Device-system and method for monitoring multiple physiological parameters (MMPP) continuously and simultaneously
US5307818A (en) 1989-02-15 1994-05-03 Jacob Segalowitz Wireless electrocardiographic and monitoring system and wireless electrode assemblies for same
US4981141A (en) 1989-02-15 1991-01-01 Jacob Segalowitz Wireless electrocardiographic monitoring system
US5168874A (en) 1989-02-15 1992-12-08 Jacob Segalowitz Wireless electrode structure for use in patient monitoring system
FR2664699B1 (fr) 1990-07-13 1995-08-18 Cis Bio Int Procede d'amplification du signal d'emission d'un compose luminescent.
US5353793A (en) 1991-11-25 1994-10-11 Oishi-Kogyo Company Sensor apparatus
US5214939A (en) 1991-11-25 1993-06-01 Carrier Corporation Variable area refrigerant expansion device having a flexible orifice
ES2155068T3 (es) 1992-04-03 2001-05-01 Micromedical Ind Ltd Sistema de supervision fisiologica.
US5522396A (en) 1992-05-12 1996-06-04 Cardiac Telecom Corporation Method and system for monitoring the heart of a patient
JP2774769B2 (ja) 1993-04-26 1998-07-09 賢治 寒川 アドレノメデュリン
US5544661A (en) 1994-01-13 1996-08-13 Charles L. Davis Real time ambulatory patient monitor
DE19847690A1 (de) 1998-10-15 2000-04-20 Brahms Diagnostica Gmbh Verfahren und Substanzen für die Diagnose und Therapie von Sepsis und sepsisähnlichen systemischen Infektionen
US6416471B1 (en) 1999-04-15 2002-07-09 Nexan Limited Portable remote patient telemonitoring system
DE10316583A1 (de) 2003-04-10 2004-10-28 B.R.A.H.M.S Aktiengesellschaft Bestimmung eines midregionalen Proadrenomedullin-Teilpeptids in biologischen Flüssigkeiten zu diagnostischen Zwecken, sowie Immunoassays für die Durchführung einer solchen Bestimmung
DE102006060112A1 (de) 2006-12-20 2008-06-26 Brahms Aktiengesellschaft Diagnose und Risikostratifizierung mittels dem neuen Marker CT-proADM
DE102007022367A1 (de) 2007-05-07 2008-11-20 B.R.A.H.M.S Ag Verfahren zur Bestimmung von aminoterminalen pro-ANP bei übergewichtigen Patienten
EP2107377A1 (en) * 2008-04-04 2009-10-07 BRAHMS Aktiengesellschaft Pro-endothelin-1 levels for the prediction of risk of tachyarrhytmic events
CN105044349B (zh) * 2010-08-26 2018-04-06 弗·哈夫曼-拉罗切有限公司 生物标志物在评估从动脉高血压向心力衰竭的早期转变中的用途
CN108931658A (zh) * 2018-04-16 2018-12-04 上海交通大学医学院附属瑞金医院 用于诊断心力衰竭合并症及预后评估的血清标记物

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
JP2022526507A5 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011610A2 (https=)
BR112023011539A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR112021013417A2 (https=)
BR102021004425A2 (https=)
BR112023008622A2 (https=)
BR102020022457A2 (https=)
BR102020021699A2 (https=)